Drugs / Nitrate Rich Beetroot Juice
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06657976 | Jan 2025 → Jul 2029 expected | intermittent vascular claudication, peripheral arterial disease | Northwestern University | Recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06686121 | Aug 2025 → Feb 2032 expected | intermittent vascular claudication, peripheral arterial disease | Northwestern University | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03644472 Comparator | Nov 2018 → Feb 2023 | — | Penn State University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitrate-Rich Beetroot Juice | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06657976 ↗ |
| Route | Oral | “Subjects will consume 140 ml of beetroot juice” NCT03644472 ↗ |